Pharmacyclics
Navigation Links
Pharmacyclics in Medical News
Pharmacyclics Sets Record Date for Rights Offering
.... To participate in the rights offering, shares of pharmacyclics would have to be purchased on or before July 10, 2...the securities laws of any such state. About pharmacyclics Pharmacyclics(R) is a clinical-stage biopharmac...forward the economic interest of its stakeholders. pharmacyclics strives to generate collaborations that allow it t...Pharmacyclics Reports Third Quarter Fiscal 2009 Financial Results
...HDAC, Btk and Factor VIIa Inhibitor programs. pharmacyclics also reported its financial results for the nine m...Laboratoires Servier ("Servier") pursuant to which pharmacyclics granted to Servier an exclusive license for its pa...t for the United States, and will pay a royalty to pharmacyclics on sales outside of the United States....Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer
...ass and first in class cancer and autoimmune therapeutics." About pharmacyclics Pharmacyclics(R) is committed to creating and developing novel pharma...rnia and is listed on NASDAQ under the symbol PCYC. To learn more about how pharmacyclics advances science to improve human healthcare visit us at http://www.pharma...Pharmacyclics Receives Nasdaq Notification
... Company will submit its plan to Nasdaq by February 25, 2009. About pharmacyclics Pharmacyclics(R) is committed to creating and developing novel pharm...rnia and is listed on NASDAQ under the symbol PCYC. To learn more about how pharmacyclics advances science to improve human healthcare visit us at http://www.pharma...Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission
...al Officer and Secretary, in writing at 995 East Arques Avenue, Sunnyvale, California 94085 or by telephone at (408) 774-0330. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule dr...Pharmacyclics Reports Third Quarter 2008 Financial Results
...sociated with the Company's HDAC, Btk and Factor VIIa inhibitor programs. pharmacyclics also reported its financial results for the nine months ended March 31, 200...e available on the company's website for one month. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer ...Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
...o http://ir.pharmacyclics.com . The archived version of the webcast will be available on the company's website for one month. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule dr...Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
...o http://ir.pharmacyclics.com . The archived version of the webcast will be available on the company's website for one month. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule dr......tases, which are estimated to occur in up to 50% of lung cancer patients. pharmacyclics recently completed patient enrollment in three Phase 2 trials evaluating Xc...linical testing for cancer and autoimmune diseases. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer ...
Pharmacyclics in Medical Technology
Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
... pharmacyclics to maintain all US Rights Conference Call to ...ment of solid tumors and hematologic malignancies. pharmacyclics expects that this alliance will enable it to aggre...t for the United States and will pay a royalty to pharmacyclics on sales outside of the United States.......orders such as rheumatoid arthritis and lupus, and pharmacyclics also has strong preclinical efficacy with PCI-3276...g a proprietary pharmacodynamic assay developed by pharmacyclics to directly assess Btk drug occupancy. Preliminar...derived from the B-cell lymphoma patients. pharmacyclics Btk Presentations at AACR Monday April 20,...
...YVALE, Calif., Feb. 20 /PRNewswire-FirstCall/ -- pharmacyclics (Nasdaq: PCYC ) announced today the close of a f...mately $1.4 million dollar private investment into pharmacyclics at $0.93/share. Robert Duggan, CEO of pharmacyclics noted, "We appreciate the vote of confidence by th...
Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
...mation of blood clots). Earlier this year, pharmacyclics presented data at the 2008 Annual Meeting of the A...vity for the Factor VIIa:TF complex. About pharmacyclics Pharmacyclics(R) is committed to creating ...daq under the symbol PCYC. To learn more about how pharmacyclics advances science to improve human healthcare visit...... uncontrolled growth of B-cells where activation of the B-cell receptor and Btk signaling are thought to play important roles. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule dr...
...chool of Medicine, and lead author of the study. pharmacyclics has been developing MGd for use in combination wit...ociety of Clinical Oncology Annual Meeting (ASCO), pharmacyclics announced final results from a Phase 2 clinical tr...nts. About Motexafin Gadolinium (MGd, Xcytrin) pharmacyclics is developing MGd as an anti-cancer agent with a n...
... solid tumors, and motexafin gadolinium, which is currently in two Phase 2 trials sponsored by the National Cancer Institute." About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule dr...
Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
...in 80 percent of the animals, with most achieving partial response. -- pharmacyclics researchers also presented a study identifying biomarkers that may be u... and inflammatory disorders while improving safety. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer ......ndidates, demonstrate the breadth of our product portfolio," said Richard A. Miller, M.D., president and CEO of Pharmacyclics. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule dr...
Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
...y's lead pan-HDAC inhibitor, PCI-24781, is currently in Phase 1 clinical trials in patients with solid and hematologic tumors. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and immune mediated diseases. The company is leveraging its small-molecule ...Pharmacyclics in Biological Technology
Pharmacyclics, Inc. Rights Offering Oversubscribed
...cised by July 31, 2009 have expired. About pharmacyclics Pharmacyclics((R)) is a clinical-stage biopharm...ndard of care in the markets it serves. Presently, pharmacyclics has four product candidates in clinical developmen...in exchange for adding to their product pipelines. pharmacyclics strives to generate collaborations that allow it t...Pharmacyclics Announces Subscription Price for Rights Offering
...n VP of Finance, at 408-215-3325. About pharmacyclics Pharmacyclics(R) is a clinical-stage biopharm...forward the economic interest of its stakeholders. pharmacyclics strives to generate collaborations that allow it t...and commercialization of its products. Presently, pharmacyclics has four product candidates in clinical developmen...Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
...able for replay through June 26, 2009. About pharmacyclics Pharmacyclics(R) is a clinical-stage biopharmac...ndard of care in the markets it serves. Presently, pharmacyclics has four product candidates in clinical developmen...in exchange for adding to their product pipelines. pharmacyclics strives to generate collaborations that allow it t...Pharmacyclics Files Registration Statement for Rights Offering
...including the repayment of certain indebtedness of pharmacyclics under an existing promissory note in favor of Robe...e up to his proportionate 27% interest and provide pharmacyclics with sufficient capital to satisfy the $6.4 millio...the securities laws of any such state. About pharmacyclics Pharmacyclics(R) is a clinical-stage biopharmac...Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
...AC, Btk and Factor VIIa inhibitor programs. pharmacyclics also reported its financial results for the six mo...9 of $500,000. Fiscal 2009 Guidance pharmacyclics projects total operating expenses, excluding share...ss and dedicated employees throughout our Company, pharmacyclics is moving forward to a brighter future." "O......ur Board," said Bob Duggan Chairman and CEO of Pharmacyclics. About pharmacyclics Pharmacyclics(R) is committed to creating and developing novel pharm...rnia and is listed on NASDAQ under the symbol PCYC. To learn more about how pharmacyclics advances science to improve human healthcare visit us at http://www.pharma...
Pharmacyclics Secures $5.0 Million in Debt Financing
... common stock. Under the terms of the loan, pharmacyclics is to pay RWD the principal sum of $5,000,000 on t...t is important to keep in mind that companies like pharmacyclics continue to discover and develop innovative medici...ure in the making at Pharmacyclics." About pharmacyclics Pharmacyclics(R) is committed to creating a...Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
...tions I wish to share with my fellow stakeholders. pharmacyclics is a company consisting of high quality people. Mo...viable than ever before. This is our intention. At pharmacyclics we are dedicated to advancing our small molecule c...ed for December 12, 2008." About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative ...Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
...due to the completion of preclinical activities. pharmacyclics also reported financial results for the fiscal yea...ties as of June 30, 2007. Fiscal 2009 Guidance pharmacyclics projects total operating expenses, excluding share...llion. Including share-based compensation expense, pharmacyclics projects total operating expenses of between $16 a...Pharmacyclics Announces It Received Nasdaq Notice of Compliance
...least 10 consecutive business days. Accordingly, Nasdaq has determined that the Company has regained compliance with the Rule. About Pharmacyclics pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and immune mediated diseases. The company is leveraging its small-molecule ...Other TagsWideBiterMicroScissorOther Contentslaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratoryventilationventilationventilationventilationventilationhighhighhighhighhighhighhighhighhighhighprogramprogramprogramprogramprogramprogramprogramprogramprogramtrainingtrainingtrainingtrainingtrainingtrainingtrainingtrainingscientistscientistscientistscientistscientistscientistwritingwritingwritingwritingwritingwriting
CarverSliderWideBiterStraigntLoosebodyOVERBITERSTINGRAYNarrowlineMicroshearsAngulatedMicroScissorBackBiterEllipticalXLS
(Date:11/24/2009)...24/PRNewswire-USNewswire/--TheBaylorCharlesA.Sammo...tcancerclinicaltrialscooperativegroupsintheUnitedS...nstitute,SouthwestOncologyGroupconductsclinicaltri...qualityoflifeforcancersurvivors. ,, "Joiningthi...rtantclinicaltrialstocancerpatientsinNorthTexas,"s...
(Date:11/24/2009)...,Nov.24/PRNewswire/--HealthPlusofMichiganhaslaunch...edspecificallyforindividuals18to64andtheirfamilies...ectly. ,, Thenew HealthPlusSignature plansareav...tsandbrokersthroughouttheHealthPlusservicearea.Mor...ilablebytoll-freephonecallto1-877-562-0907. ,, ...
(Date:11/24/2009)... Physician recruiting firm LocumTenens.com, ..., is pleased to announce its agreement with VHA In...icians for locum tenens assignments. , ...2009 -- Physician recruiting firm LocumTenens.c...ffing, is pleased to announce its agreement with V...
(Date:11/24/2009)...Mich.,Nov.24/PRNewswire/--Mostpeoplelookforwardtok...ttingtogetherwithfriendsandfamily.TheMacombCountyH...thduringtheholidays.Travelingandbeinginlargegroups...epstostayhealthy: ,, VACCINATION ,, Thefir...egoriestogetvaccinatedagainsttheH1N1strainoftheflu...
(Date:11/24/2009)...Calif.,Nov.24/PRNewswire/--AgitoNetworks,Inc.,thec...ility,todayannouncedthatitwashonoredintheEverythin...nywhereMobilityRouterv3.0.EverythingChannel,sTechI...troducednewsolutionsthatdriveadvancesthroughoutthe...nterreviewedhundredsofapplicationsforthe2009Everyt...
Breaking Medicine News(10 mins):Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3[0] Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups[0] HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own[1] VHA Names LocumTenens.com as Preferred Physician Staffing Vendor[2] Tips To Enjoy a Flu-Free Holiday Season[2] Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel
(Date:11/23/2009)...des "incontrovertible evidence" that the volcanic ...out 73,000 years ago deforested much of central In...ers report. , The volcano ejected an estimated 8...aving a crater (now the world,s largest volcanic l... wide. Ash from the event has been found in India,...
(Date:11/23/2009)... University of Alabama at Birmingham (UAB) researc...ing medical conditions (co-morbidity) do not expla...mericans compared to Caucasians who also have colo... Cancer , a journal of the American Cancer Societ... co-morbidity are independent predictors of poor s...
(Date:11/23/2009)...discoveries about the multiple health benefits of ...se nutrient, increased awareness of the huge numbe...arch and even led to an appreciation of it as "nat...health of your immune system to prevention of hear...amin D is now seen as one of the most critical nut...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3FaxBack Announces a New VoIP Fax ATA based on HTTPS Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 56102 1FaxBack Announces a New VoIP Fax ATA based on HTTPS Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 56102 2Find Qualified Consulting Firms Quickly and Efficiently 56097 1Find Qualified Consulting Firms Quickly and Efficiently 56097 2Find Qualified Consulting Firms Quickly and Efficiently 56097 3NTU professor bags inaugural award honoring women in science 13812 1NTU professor bags inaugural award honoring women in science 13812 2NTU professor bags inaugural award honoring women in science 13812 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |